Anna Karpathakis
38 works · 1,180 citations · h-index 12
Top works
- Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
- Deciphering the genomic, epigenomic, and transcriptomic landscapes of pre-invasive lung cancer lesions
- Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
- Bone metastases in germ cell tumours: lessons learnt from a large retrospective study
- Surgical management and palliative treatment in bronchial neuroendocrine tumours: A clinical study of 45 patients
- Epigenetic dysregulation and poorer prognosis in DAXX-deficient pancreatic neuroendocrine tumours
- Metformin for patients with metastatic prostate cancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol
- Neuroendocrine tumours: cracking the epigenetic code
- Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases
- Assessment of RainDrop BS-seq as a method for large-scale, targeted bisulfite sequencing
- Toxicity associated with capecitabine plus oxaliplatin in colorectal cancer before and after an institutional policy of capecitabine dose reduction
- Well‐differentiated bronchial neuroendocrine tumors: Clinical management and outcomes in 105 patients
- Hitting the target: where do molecularly targeted therapies fit in the treatment scheduling of neuroendocrine tumours?
- Pancreatic Adenocarcinoma in a Patient With Multiple Endocrine Neoplasia 1 Syndrome
- Genome-wide DNA methylation profiling of gastrointestinal neuroendocrine tumors to identify hypermethylation of mTOR, Wnt, and Notch pathways in GI NET pathogenesis.
- Testicular germ cell tumors with bony metastases: Diagnosis, management, and outcomes (a case series).
- Plasma AR Alterations and Timing of Intensified Hormone Treatment for Prostate Cancer
- Supplementary Table 4 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor
- The new radiolabelled somatostatin analogue 90Yttrium-dota-octreotate for the treatment of metastatic neuroendocrine tumors: Initial results and tolerability in a series of 47 patients
- Supplementary figures S1-4 from Prognostic Impact of Novel Molecular Subtypes of Small Intestinal Neuroendocrine Tumor